Phase II Trial of Rituximab and Short Duration Chemotherapy Followed by Zevalin as First-Line Treatment for Patients With Low Grade Follicular Non-Hodgkin's Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2015
At a glance
- Drugs Ibritumomab tiuxetan (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Sponsors Biogen
- 30 Jan 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 21 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Jan 2006 New trial record.